Menu
Study finds paxlovid treatment does not lower risk of long Covid
Paxlovid (Nirmatrelvir-ritonavir) did not decrease the chance of developing long COVID in vaccinated,...
Hetero's 'Nirmacom' first generic version of COVID-19 drug
Hyderabad (Telangana) [India], December 27 (ANI/PRNewswire): Hetero, India's leading pharmaceutical company with the...
Zenara Pharma launches Paxzen tablet against mild to moderate COV
Hyderabad (Telangana) [India], September 9 (ANI): Hyderabad-based Zenara Pharma, has announced that it has...
Four drugs for COVID-19 appear to have little or no effect on...
New Delhi [India], October 17 (ANI): The interim analysis of WHO's Solidarity Trial has revealed that 4 repurposed...
Four repurposed drugs have no effect on reducing mortality in...
New Delhi [India], October 16 (ANI): The interim analysis of World Health Organisation (WHO)'s Solidarity Trial has...
WHO halts hydroxychloroquine and combination of HIV drug...
Geneva [Switzerland], July 5 (ANI) The World Health Organisation on Saturday has halted its trials of the malaria...
UK's RECOVERY trial found anti-viral HIV drug "ineffective"on...
New Delhi [India], June 30 (ANI): Researchers from UK's RECOVERY trial (Randomised Evaluation of COVID-19 Therapy)...
COVID-19: Anti-HIV drugs administered on Italian couple at...
New Delhi [India], Mar 10 (ANI): In a first in India, doctors at SMS hospital in Jaipur have administrated the...
"LOPIKAST: A drug to fight against coronavirus"
New Delhi [India] Feb 8 (ANI/NewsVoir): The endemic of coronavirus started from Wuhan city of China and is knocking...
Mixture of anti-HIV drugs may be used to treat nCoV patients...
New Delhi [India], Feb 5 (ANI): In a significant move, the India Council of Medical Research (ICMR) has sought an...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.